Pharmaceutical Preparations · DE · CIK 1369568
Catalyst Pharmaceuticals, Inc. develops and commercializes treatments for rare neurological diseases
Comparable business profile · signals at a glance
In the 90 days to Dec 12, 2025: 3 sold $1.8M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 12, 2025 | Harper MollyDirector | Sell | 15,527 | $23.20 | $360K |
| Dec 12, 2025 | Harper MollyDirector | Sell | 6,746 | $23.06 | $156K |
| Dec 12, 2025 | Harper MollyDirector | Sell | 4,473 | $23.73 | $106K |
| Nov 26, 2025 | Del Carmen JeffreyChief Commercial Officer | Sell | 10,983 | $23.33 | $256K |
| Nov 12, 2025 | Elsbernd BrianChief Compliance/Legal Officer | Sell | 40,000 | $22.70 | $908K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.